Literature DB >> 16538453

Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.

Wei Gao1, Yu-Sheng Wang, Peng Zhang, Hai-Yan Wang.   

Abstract

PURPOSE: To determine whether hyperhomocysteinemia and low plasma folate are risk factors for central retinal vein occlusion (CRVO) in the Chinese population.
METHODS: A matched case-control study was conducted between July 2004 and May 2005. The study cohort consisted of 64 individuals that had been diagnosed to have CRVO and 64 normal controls (matched for age, gender, hypertension, smoking and drinking habits). None of the cases or controls had a history of diabetes, glaucoma, medication or any other vascular events that might minimize the influence on plasma homocysteine levels. A cross-sectional analysis among the 64 cases was performed to compare the prevalence of hyperhomocysteinemia and low plasma folate among subjects with and without ischemia and subjects with age above 45 and below 45 years. Plasma homocysteine level was measured by means of high-performance liquid chromatography and plasma folate concentration by radioimmunoassay.
RESULTS: The CRVO patients had a significantly higher homocysteine level (13.83+/-1.71 micromol/l) than the normal controls (8.05+/-0.58 micromol/l; p=0.003). The plasma folate levels were significantly lower in CRVO patients than in controls (5.62+/-0.39 ng/dl vs 7.23+/-0.60 ng/dl; p=0.032). A 1 micromol/l increase of plasma homocysteine level was associated with an odds ratio of 1.368. Hyperhomocysteinemia was defined as a homocysteine level of >14.97 micromol/l and was seen in 11 patients in the ischemic group, significantly more often than in the non-ischemic group (5 patients; p=0.030).
CONCLUSIONS: The results suggest that hyperhomocysteinemia and low plasma folate are independent risk factors for CRVO and are associated with the development of CRVO in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538453     DOI: 10.1007/s00417-005-0191-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease.

Authors:  R de Franchis; F P Mancini; A D'Angelo; G Sebastio; I Fermo; V de Stefano; M Margaglione; G Mazzola; G di Minno; G Andria
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

Authors:  M R Malinow; F J Nieto; W D Kruger; P B Duell; D L Hess; R A Gluckman; P C Block; C R Holzgang; P H Anderson; D Seltzer; B Upson; Q R Lin
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

3.  Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion.

Authors:  Martin Weger; Olaf Stanger; Hannes Deutschmann; Werner Temmel; Wilfried Renner; Otto Schmut; Franz Quehenberger; Jürgen Semmelrock; Anton Haas
Journal:  Ophthalmology       Date:  2002-06       Impact factor: 12.079

4.  Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.

Authors:  S Boyd; D Owens; T Gin; K Bunce; H Sherafat; D Perry; P G Hykin
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

Review 5.  Homocysteine and cardiovascular disease.

Authors:  H Refsum; P M Ueland; O Nygård; S E Vollset
Journal:  Annu Rev Med       Date:  1998       Impact factor: 13.739

6.  Hematologic abnormalities associated with various types of retinal vein occlusion.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman; Patricia Podhajsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-02-09       Impact factor: 3.117

7.  Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.

Authors:  M R Malinow; F J Nieto; M Szklo; L E Chambless; G Bond
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

8.  Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease.

Authors:  J G Ray
Journal:  Arch Intern Med       Date:  1998-10-26

9.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.

Authors:  A M Engbersen; D G Franken; G H Boers; E M Stevens; F J Trijbels; H J Blom
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  [Hyperhomocysteinemia as a risk factor for central retinal vein thrombosis in a young patient].

Authors:  M M Cabezas-León; M R García-Montero; P Morente-Matas
Journal:  Rev Neurol       Date:  2003 Sep 1-15       Impact factor: 0.870

View more
  10 in total

1.  Increased ER stress as a mechanism of retinal neurovasculopathy in mice with severe hyperhomocysteinemia.

Authors:  Amany Tawfik; Sylvia B Smith
Journal:  Austin J Clin Ophthalmol       Date:  2014-06-16

2.  Hyperhomocysteinemia, as an independent risk factor for retinal venous occlusion in an Indian population.

Authors:  Kapil D Lahiri; Jayanta Dutta; Himadri Datta; Harendra N Das
Journal:  Indian J Clin Biochem       Date:  2012-07-04

3.  Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality.

Authors:  Jane Zea-Chin Kuo; Chi-Chun Lai; Frank Shih-Chang Ong; Chia-Pang Shih; Ling Yeung; Tun-Lu Chen; Kuan-Jen Chen; Wei-Chi Wu
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

4.  A longitudinal analysis of risk factors associated with central retinal vein occlusion.

Authors:  Maxwell S Stem; Nidhi Talwar; Grant M Comer; Joshua D Stein
Journal:  Ophthalmology       Date:  2012-11-20       Impact factor: 12.079

5.  Hyperhomocysteinemia and central retinal vein occlusion in Iranian population.

Authors:  Sasan Moghimi; Zahra Najmi; Hooshang Faghihi; Reza Karkhaneh; Mohammad Sadegh Farahvash; Maryam Maghsoudipour
Journal:  Int Ophthalmol       Date:  2007-07-17       Impact factor: 2.031

6.  Presumed bilateral branch retinal vein occlusions secondary to antiepileptic agents.

Authors:  Rumana N Hussain; Somnath Banerjee
Journal:  Clin Ophthalmol       Date:  2011-05-13

Review 7.  Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis.

Authors:  Dan Li; Minwen Zhou; Xiaoyan Peng; Huiyu Sun
Journal:  BMC Ophthalmol       Date:  2014-11-27       Impact factor: 2.209

8.  Role of hyperhomocysteinemia and Vitamin B12 deficiency in central and hemi-central retinal vein occlusion: A case-control study.

Authors:  Dhipak Arthur; Deepa John; Jude Joseph Fleming; Grace Rebekah; Mahasampath Gowri; Sheeja Susan John
Journal:  Oman J Ophthalmol       Date:  2022-03-02

9.  Hyperhomocysteinia is a risk factor for retinal venous occlusion: a case control study.

Authors:  Fahad Al Wadani; Rajiv Khandekar; Gigani Salim; Mohammed Al Ali; Salman Ramzi
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

10.  Thrombophilic risk factors for retinal vein occlusion.

Authors:  Maria J Vieira; António Campos; Anália do Carmo; Henrique Arruda; Joana Martins; João P Sousa
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.